ROS-Responsive Nanoparticles with Antioxidative Effect for the treatment of Diabetic Retinopathy
Jinjin Li Yujia Liu Kedui Geng Xin Lu Xiangchun Shen Qianqian Guo a The Department of Pharmacology,School of Basic Medical Sciences,Guizhou Medical University,Guiyang,Guizhou Province,Chinab The Department of Pharmacology of Materia Medica (the High Efficacy Application of Natural Medicinal Resources Engineering Center of Guizhou Province,the Key Laboratory of Optimal Utilization of Natural Medicine Resources),School of Pharmaceutical Sciences,Guizhou Medical University,Guiyang,Guizhou Province,Chinac The Guizhou Provincial Scientific and Technologic Innovation Base ([2023]003),Guizhou Medical University,Guiyang,Guizhou Province,Chinad The State Key Laboratory of Functions and Applications of Medicinal Plants,School of Pharmaceutical Sciences,Guizhou Medical University,Guiyang,Guizhou Province,China
DOI: https://doi.org/10.1080/09205063.2024.2406628
2024-09-26
Journal of Biomaterials Science Polymer Edition
Abstract:Diabetic retinopathy (DR) is a common microvascular complication of diabetes necessitating early intervention to impede progression, despite current clinical treatments focusing on advanced stages. Essential oils from Fructus Alpiniae zerumbet (EOFAZ) have demonstrated efficacy in protecting against high glucose (HG)-induced Müller cell activation and DR development. This study introduced a reactive oxidative species (ROS)-responsive drug delivery system (NPS PHE @EOFAZ) targeting early DR stages and oxidative stress. Our engineered nanoparticles effectively deliver EOFAZ into HG-exposed Müller cells by detecting and responding to elevated oxidative stress levels. The NPS PHE @EOFAZ significantly inhibited abnormal cell growth, reduced oxidative stress, and alleviated inflammation in vitro. In vivo experiments on diabetic mice with DR revealed that NPS PHE @EOFAZ mitigated early pathological changes by reducing oxidative stress and inflammation while also alleviating organ damage in the heart, liver, spleen, lung, and kidney. These findings underscore the potential of NPS PHE @EOFAZ as a promising antioxidant for early intervention in DR pathogenesis.
engineering, biomedical,materials science, biomaterials,polymer science